Arg92Leu-cTnT Alters the cTnC-cTnI Interface Disrupting PKA-Mediated Relaxation

Melissa L Lynn1, Jesus Jimenez2, Romi L Castillo1

  • 1Department of Biomedical Engineering (M.L.L., R.L.C., C.G., J.C.T.), University of Arizona, Tucson.

Circulation Research
|September 27, 2024
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) mutations cause early diastolic dysfunction by altering the cardiac troponin C-cardiac troponin I interface, reducing PKA accessibility. This molecular insight reveals a potential therapeutic target for HCM treatment.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biophysics

Background:

  • Diastolic dysfunction in hypertrophic cardiomyopathy (HCM) is linked to impaired left ventricular relaxation and calcium handling.
  • Early relaxation deficits in preclinical HCM suggest myofilament regulators are involved.
  • Molecular mechanisms underlying myofilament dysfunction in HCM remain unclear.

Purpose of the Study:

  • To investigate how HCM-specific mutations in cardiac troponin T (cTnT) affect diastolic function at the myofilament level.
  • To elucidate the role of the cardiac troponin C (cTnC)-cardiac troponin I (cTnI) interface in mutation-specific diastolic dysfunction.
  • To identify potential molecular targets for therapeutic intervention in HCM.

Main Methods:

  • Studied HCM mutations R92L-cTnT and Δ160E-cTnT using in vivo, in vitro, and in silico approaches.
  • Employed 2D echocardiography, Western blotting, ex vivo hemodynamics, stopped-flow kinetics, time-resolved fluorescence resonance energy transfer (TR-FRET), and molecular dynamics simulations.
  • Probed the cTnC-cTnI interface using TR-FRET to assess structural changes and PKA accessibility.

Main Results:

  • HCM mutations R92L-cTnT and Δ160E-cTnT exhibited distinct onsets of diastolic dysfunction.
  • R92L-cTnT mutation led to early diastolic dysfunction and reduced cTnI phosphorylation.
  • TR-FRET revealed mutation-specific structural changes at the cTnC-cTnI interface, repositioning cTnI and affecting PKA consensus sites.

Conclusions:

  • Early diastolic dysfunction in HCM can result from allosteric changes at the cTnC-cTnI interface.
  • These structural alterations impair protein kinase A (PKA) accessibility, blunting beta-adrenergic response.
  • The cTnC-cTnI interface represents a potential molecular target for treating HCM-related diastolic dysfunction.
Abstract

Related Concept Videos

Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
4.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K